T Struller. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Bacteria/drug effectsChemistry, PharmaceuticalDelayed-Action PreparationsEscherichia coli/drug effectsHydrogen-Ion ConcentrationLipidsMetabolic Clearance RateProtein BindingSolubilitySulfadiazine/metabolismSulfadimethoxine/metabolismSulfamerazine/metabolismSulfamethoxazole/therapeutic useSulfamethoxypyridazine/metabolismSulfathiazoles/metabolismSulfisoxazole/metabolismSulfonamides/classificationSulfonamides/metabolismTime FactorsUrinary Tract Infections/drug therapy
Substances： See more » Delayed-Action PreparationsLipidsSulfathiazolesSulfonamidesSulfadiazineSulfadimethoxineSulfisoxazoleSulfamethoxazoleSulfamethoxypyridazineSulfamerazine
Year: 1968 PMID： 4883637 DOI： 10.1159/000386763
Source DB: PubMed Journal: Antibiot Chemother